Artivion, Inc. (AORT) Insider Trading
Directors, officers and holders of more than 10% of AORT report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 219 transactions on file: 0 with code P, 27 with code S and 23 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 11,480 | $24.97 | $286,656 |
| Sep 3, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 1,493 | $26.02 | $38,842 |
| Sep 2, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 6,510 | $27.27 | $177,495 |
| Aug 19, 2026 | Mackin James P | President & CEO | S Sale | 70,000 | $28.95 | $2,026,850 |
| Aug 14, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 616 | $28.55 | $17,586 |
| Aug 14, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 715 | $28.55 | $20,413 |
| Aug 12, 2026 | Holloway Jean F | SVP, General Counsel | S Sale | 977 | $28.49 | $27,835 |
| Jun 11, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | M Exercise | 14,001 | $18.44 | $258,178 |
| Jun 11, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | M Exercise | 30,000 | $11.03 | $330,900 |
| Jun 11, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 30,000 | $20.69 | $620,820 |
| Jun 11, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 14,001 | $20.71 | $289,919 |
| Jun 11, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | M Exercise | 30,000 | Not measured | Not measured |
| Jun 11, 2026 | GREEN ANDREW M | SVP, Regulatory and Quality | M Exercise | 14,001 | Not measured | Not measured |
| Jun 2, 2026 | SEMEDO ANTHONY B. | Director | J Other | 6,325 | Not measured | Not measured |
| Jun 2, 2026 | SEMEDO ANTHONY B. | Director | J Other | 6,325 | Not measured | Not measured |
| May 18, 2026 | SEMEDO ANTHONY B. | Director | A Award | 7,576 | Not measured | Not measured |
| May 18, 2026 | Borgstrom Marna P | Director | A Award | 7,576 | Not measured | Not measured |
| May 18, 2026 | Salveson Jon W | Director | A Award | 7,576 | Not measured | Not measured |
| May 18, 2026 | Hoff Elizabeth A | Director | A Award | 7,576 | Not measured | Not measured |
| May 18, 2026 | ACKERMAN THOMAS F | Director | A Award | 7,576 | Not measured | Not measured |
| May 18, 2026 | Bullock James | Director | A Award | 7,576 | Not measured | Not measured |
| May 18, 2026 | BEVEVINO DANIEL J | Director | A Award | 7,576 | Not measured | Not measured |
| May 18, 2026 | Burbank Jeffrey H | Director | A Award | 7,576 | Not measured | Not measured |
| May 14, 2026 | Borgstrom Marna P | Director | A Award | 7,850 | Not measured | Not measured |
| Mar 4, 2026 | Holloway Jean F | SVP, General Counsel | S Sale | 8,962 | $38.00 | $340,556 |
| Mar 3, 2026 | Holloway Jean F | SVP, General Counsel | S Sale | 3,843 | $37.78 | $145,172 |
| Mar 3, 2026 | Davis John E | Chief Commercial Officer | S Sale | 4,573 | $37.78 | $172,748 |
| Mar 3, 2026 | Horton Amy | VP, Chief Accounting Officer | S Sale | 901 | $37.78 | $34,036 |
| Mar 3, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2,149 | $37.78 | $81,180 |
| Mar 3, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 6,316 | $37.78 | $238,591 |
| Mar 3, 2026 | Mackin James P | President & CEO | S Sale | 17,887 | $37.78 | $675,692 |
| Mar 2, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 5,178 | $38.02 | $196,893 |
| Mar 2, 2026 | Davis John E | Chief Commercial Officer | S Sale | 2,784 | $38.02 | $105,861 |
| Mar 2, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | A Award | 40,874 | Not measured | Not measured |
| Mar 2, 2026 | Horton Amy | VP, Chief Accounting Officer | S Sale | 641 | $38.02 | $24,374 |
| Mar 2, 2026 | Mackin James P | President & CEO | S Sale | 14,911 | $38.02 | $566,989 |
| Mar 2, 2026 | Holloway Jean F | SVP, General Counsel | A Award | 27,795 | Not measured | Not measured |
| Mar 2, 2026 | Holloway Jean F | SVP, General Counsel | S Sale | 2,183 | $38.02 | $83,008 |
| Mar 2, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | A Award | 21,838 | Not measured | Not measured |
| Mar 2, 2026 | Horton Amy | VP, Chief Accounting Officer | A Award | 7,475 | Not measured | Not measured |
| Mar 2, 2026 | Mackin James P | President & CEO | A Award | 116,948 | Not measured | Not measured |
| Mar 2, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 1,513 | $38.02 | $57,532 |
| Mar 2, 2026 | Davis John E | Chief Commercial Officer | A Award | 28,845 | Not measured | Not measured |
| Feb 24, 2026 | Mackin James P | President & CEO | S Sale | 13,936 | $35.69 | $497,418 |
| Feb 24, 2026 | Mackin James P | President & CEO | A Award | 97,030 | Not measured | Not measured |
| Feb 24, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 4,485 | $35.69 | $160,083 |
| Feb 24, 2026 | Horton Amy | VP, Chief Accounting Officer | S Sale | 830 | $35.69 | $29,625 |
| Feb 24, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 1,259 | $35.69 | $44,937 |
| Feb 24, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | A Award | 37,482 | Not measured | Not measured |
| Feb 24, 2026 | Davis John E | Chief Commercial Officer | S Sale | 2,075 | $35.69 | $74,063 |
The full Form 4 history is on the AORT company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.